Results 151 to 160 of about 31,793 (243)

Establishing FDA-approved oncology drugs as GPR176 inhibitor through homology modelling, molecular docking, MMGBSA, DFT, and molecular dynamics simulation. [PDF]

Sci Rep
Ishabiyi FO, Umar HI, Dutta T, Onyinye OC, Damola OD, Budagova L, Temesgen D, Bourhia M, Bello RO, Alyami EM, Alsolami M, Almohammed OA.   +11 more
europepmc   +1 more source

Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel

, 2019
Engin Algül, Hamza Sunman, Muhammet Dural, İlkin Gulıyev, Mert Aker, Mehmet Ali Felekoğlu, Mehmet Erat, Murat Tulmaç, Sadık Açıkel, Tolga Çimen   +9 more
openalex   +1 more source

PCV50 Cost-Effectiveness Analysis of Treating Acute Coronary Syndrome Patients With Ticagrelor Versus Clopidogrel in Hong Kong: A Markov Analytic Model [PDF]

, 2012
Vivian Lee, I.H.I. Chow, Bernard Yan, Cheuk‐Man Yu, Yat‐Yin Lam   +4 more
openalex   +1 more source

Discovery and Evaluation of Novel Calenduloside E Derivatives Targeting HSP90β in Ox-LDL-Induced HUVECs Injury. [PDF]

Pharmaceuticals (Basel)
Han F, Fang H, Li G, Deng D, Sun G, Tian Y.   +5 more
europepmc   +1 more source

A cecal slurry mouse model of polymicrobial abdominal sepsis to evaluate the effects of antiplatelet agents. [PDF]

Res Pract Thromb Haemost
Mansour A, Gouin-Thibault I, Rossi E, Marchelli A, Belleville-Rolland T, Nesseler N, Gaussem P, Bachelot-Loza C.   +7 more
europepmc   +1 more source

Short dual antiplatelet therapy after PCI with Resolute Onyx drug-eluting stents in high bleeding risk patients: One-year outcomes from a South Asian cohort. [PDF]

Am Heart J Plus
Jariwala P, Vallapuri GS, Konda BKR, Jangam SK.   +3 more
europepmc   +1 more source

Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus [PDF]

, 2016
Parker, W.A.E., Storey, R.F.
core   +1 more source

Prolonged ventricular pause associated with ticagrelor use: A case report

, 2021
Alaa Rahhal, Amer Aljundi, Sara S. Mohamed, Muhammad Arif, Abdul Rahman Arabi   +4 more
openalex   +1 more source

Pharmacological Evaluation of Ticagrelor and Aspirin Versus Clopidogrel and Aspirin Pretreatment on Infarct Artery Flow in Patients with Acute STEMI. [PDF]

Pharmaceuticals (Basel)
Opancina M, Opancina V, Milosavljević MN, Pejčić AV, Stepovic M, Jovic Z.   +5 more
europepmc   +1 more source

Ticagrelor as compared to conventional antiplatelet agents in coronary artery disease: A comprehensive meta-analysis of 15 randomized trials

, 2020
Monica Verdoia, Stefano Savonitto, Dariusz Dudek, Elvin Kedhi, Giuseppe De Luca   +4 more
openalex   +2 more sources